Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report.

MLA

Castellanos, Gonzalo, et al. “Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report.” Biomedicines, vol. 12, no. 3, Feb. 2024. EBSCOhost, https://doi.org/10.3390/biomedicines12030512.

APA

Castellanos, G., Pardo, L., López, A., Cornago, J., López, J. L., de Las Heras, A., Díaz, F. J., Martínez de Bourio, M., Castillo, E., Llamas, P., & Solán, L. (2024). Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report. Biomedicines, 12(3). https://doi.org/10.3390/biomedicines12030512

Chicago

Castellanos, Gonzalo, Laura Pardo, Alberto López, Javier Cornago, Jose Luis López, Alicia de Las Heras, Francisco J Díaz, et al. 2024. “Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report.” Biomedicines 12 (3). doi:10.3390/biomedicines12030512.